Semaglutide vs Tirzepatide: Which Weight-Loss Shot Wins?

Semaglutide and tirzepatide are once-weekly, injectable hormone mimics that dull appetite and slow stomach emptying so you naturally eat less and lose weight. Tirzepatide activates two gut-hormone receptors (GIP and GLP-1), giving it a metabolic “one-two punch” that trims roughly 21% of body weight in large trials, while semaglutide stimulates GLP-1 alone and averages about 15% loss. Choosing between them comes down to cost, tolerability, and how much weight you need to shed—Rx.com offers compounded versions of both drugs so you can decide based on science, not sticker shock.

• Tirzepatide led to an average 20.7 % body-weight reduction at its top dose after 72 weeks, about 6 percentage points more than semaglutide 2.4 mg in parallel studies.  [tirzepatidereview.com]
• Most patients reach their goal weight 4–6 months faster on tirzepatide because the drug can be titrated to full strength in 12 weeks instead of 20 weeks for semaglutide.  [nejm.org]
• Common side effects—nausea, burping and constipation—occur with both, but severe stomach upset is reported in roughly 6 % of semaglutide users versus 5 % on tirzepatide.  [nejm.org]
• Brand-name semaglutide (Ozempic/Wegovy) retails near $1,049 per month, while brand tirzepatide (Mounjaro/Zepbound) averages $1,069; compounded versions through Rx.com run $119–$389.  [mademed.com]
• Patients with more than 50 pounds to lose or weight-related complications (sleep apnea, fatty liver) often benefit most from tirzepatide’s extra potency, but semaglutide is a proven option when budget or GI tolerability is paramount.
• Call your prescriber if vomiting prevents hydration, you notice mid-upper-abdomen pain that radiates to your back, or blood sugars drop below 70 mg/dL on diabetes medication.

What Semaglutide and Tirzepatide Are—FDA context in one minute

Semaglutide is a GLP-1 receptor agonist first approved as Ozempic for type 2 diabetes in 2017 and later as Wegovy for chronic weight management. Tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, acts on both GIP and GLP-1 receptors, giving it dual incretin activity. Compounded semaglutide or tirzepatide contains the identical active molecule produced by an FDA-registered 503A pharmacy when brand pens are on shortage, allowing legal access at lower cost under a valid prescription.

How They Work Inside Your Body

Both medications mimic gut hormones that tell your brain you are full, but tirzepatide hits two receptors while semaglutide targets one. By activating GLP-1, semaglutide slows gastric emptying, boosts insulin release when glucose is high, and reduces food cravings. Tirzepatide adds GIP receptor activation, which appears to synergize with GLP-1 to increase energy expenditure and further blunt hunger signals, translating to greater fat-mass loss. Animal studies suggest GIP-GLP-1 co-agonism may also improve lipid metabolism beyond what GLP-1 alone can do.

How Effective Is Each Shot for Weight Loss?

Tirzepatide shows superior average weight loss in both diabetes and non-diabetes trials, but semaglutide still delivers clinically meaningful results.

Real-world results collected through Rx.com’s 6-week Ozempic plan mirror these findings: most users lose 4–6 % of starting weight at three months on semaglutide and 7–10 % on tirzepatide when paired with protein-forward diets.

Side Effects Head-to-Head

Gastrointestinal complaints dominate for both drugs, yet the overall discontinuation rate is low—about 5 % for tirzepatide and 6 % for semaglutide in pivotal studies.

Mitigation tips: start doses after the largest meal, chew food thoroughly, stay hydrated, and consider fiber plus electrolytes. Prescription antiemetics like ondansetron (not yet on Rx.com) can also help when needed.

Price Check: Brand Pens vs Compounded Vials

Compounded formulas slash the monthly bill by roughly 70 %—and Rx.com lets you compare real-time prices in seconds. Remember to factor in consultation fees and injection supplies.

For deeper dives into strategy, see our guides on buying semaglutide online safely and finding the cheapest tirzepatide.

Who Should Choose Which Drug?

The right pick balances potency, budget, and side-effect tolerance.

Semaglutide may be better when:

• You need to lose 10–40 lbs and prefer a gentler titration schedule.
• Your insurance covers Wegovy or you can access low-cost compounded semaglutide.
• You have chronic pancreatitis risk and want a longer safety track record.

Tirzepatide may be better when:

• You aim to lose more than 40 lbs or have aggressive metabolic goals.
• You can tolerate faster dose escalation without severe nausea.
• You have both obesity and pre-diabetes and want maximal A1c reduction.

How to Switch Between Semaglutide and Tirzepatide Safely

You usually wait one week after the last semaglutide shot before starting tirzepatide at the 2.5 mg “starter” dose, or vice-versa. Titrate just as you would a new user—do not jump straight to the previous high dose, or side effects spike. Our switching guide contains a week-by-week calendar.

Meal size and timing: keep meals fist-sized for 48 hours after each up-titration. Drug interactions: monitor any sulfonylurea or insulin dose closely to avoid hypoglycemia. Lifestyle factors: resistance training twice weekly helps preserve lean mass when switching to the more potent tirzepatide.